India’s Draft Pharma Policy In Trouble Again
This article was originally published in PharmAsia News
Executive Summary
NEW DELHI - India's much-delayed draft pharmaceutical policy, which was expected to be vetted by the Group of Ministers at its latest meeting on April 30, seems to have run into rough weather yet again